Physician

Andrew J. Mcdavid, MD

According to 2025 Medicare claims, Andrew Mcdavid, MD (NPI: 1477514479) practices anesthesiology in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is INTEGRATED PAIN ASSOCIATES PLLC (NPI: 1689800419; TIN: 900491630) and primary practice location at 76502-3513.

Mcdavid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 5,373 HCPCS/CPT codes, and received $248,428 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 5,971 prescription claims across 669 beneficiaries totaling $204,648 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2020 DME data shows 12 claims. Open Payments data shows 44 records totaling $1,181. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $301,726 to $248,428. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $121,301 and ending at $204,648. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$380K$759K2015 Medicare payment: $301,726 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $512,955 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $759,207 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $677,704 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $632,718 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $617,568 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $519,968 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $281,497 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $249,616 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $248,428 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156436,559$301,726
201685710,184$512,955
20171,23412,934$759,207
20181,19110,345$677,704
20191,15211,034$632,718
20201,09210,181$617,568
20219617,830$519,968
20227595,298$281,497
20233405,104$249,616
20243385,373$248,428

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$102K$205K2015 Drug cost: $121,301 (USD; Tot_Drug_Cst)2016 Drug cost: $170,322 (USD; Tot_Drug_Cst)2017 Drug cost: $198,418 (USD; Tot_Drug_Cst)2018 Drug cost: $152,155 (USD; Tot_Drug_Cst)2019 Drug cost: $98,829 (USD; Tot_Drug_Cst)2020 Drug cost: $103,209 (USD; Tot_Drug_Cst)2021 Drug cost: $156,170 (USD; Tot_Drug_Cst)2022 Drug cost: $122,835 (USD; Tot_Drug_Cst)2023 Drug cost: $172,557 (USD; Tot_Drug_Cst)2024 Drug cost: $204,648 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154581,881$121,301
20165202,680$170,322
20177092,759$198,418
20186492,340$152,155
20196722,298$98,829
20207972,894$103,209
20218974,216$156,170
20228663,793$122,835
20236184,771$172,557
20246695,971$204,648

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.2K$12K2015 Medicare payment: $12,392 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $11,811 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $8,558 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $9,769 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151516$12,392
20161313$11,811
20171212$8,558
2018N/RN/RN/R
2019N/RN/RN/R
20201212$9,769
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0483Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms5353$242
G0482Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms177346$193
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3091,167$88
80307Testing for presence of drug, by chemistry analyzers189369$59
J1100Injection, dexamethasone sodium phosphate, 1 mg631,141$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,26865,086$76,158
PregabalinPregabalin66920,479$13,407
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen39310,901$13,362
BuprenorphineBuprenorphine471,324$12,170
BelbucaBuprenorphine Hcl13390$11,159

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$1,181Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew J. Mcdavid, MD?

Tedicare shows public-source Medicare data for Andrew J. Mcdavid, MD (NPI 1477514479), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew J. Mcdavid, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew J. Mcdavid, MD?

Andrew J. Mcdavid, MD is linked to INTEGRATED PAIN ASSOCIATES PLLC (billing NPI 1689800419) in the available physician profile data.

Does Andrew J. Mcdavid, MD have Open Payments data?

Andrew J. Mcdavid, MD has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.